Century Therapeutics, Inc. (IPSC) Operating cash flow 2020–2025
Century Therapeutics, Inc. (IPSC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$103.9MFY2025 · since FY2020: -$41.3M → -$103.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$103.9M | +5.7% |
| FY2024 | -$110.1M | -24.7% |
| FY2023 | -$88.3M | -728.7% |
| FY2022 | $14.1M | +115.8% |
| FY2021 | -$89.0M | -115.7% |
| FY2020 | -$41.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice